Thursday, November 16, 2023 12:27 AM
(SIX/NYSE:ALC), a global leader in eyecare, reported its financial results for the three and nine months ended Sept. 30, 2023. For the third quarter of 2023, sales were $2.3 billion, an increase of 8 percent on a reported basis and 9 percent on a constant currency basis, as compared to the same quarter of the previous year. Sales for the first nine months of 2023 were $7.0 billion, an increase of 8 percent on a reported basis and 11 percent on a constant currency basis, compared to the first nine months of 2022.
Wednesday, November 15, 2023 12:24 AM
SAN FRANCISCO—Ray Therapeutics
, a leading optogenetics company, announced that the California Institute for Regenerative Medicine
has awarded the company a $4 million grant to support development of RTx-021, an optogenetic therapy for the treatment of geographic atrophy (GA).
Wednesday, November 15, 2023 12:18 AM
, a leading U.S. eyecare pharmaceutical company, announced results for the third quarter and nine months ended Sept. 30, 2023. The company reported record revenues of $34.3 million.
Monday, November 13, 2023 12:21 AM
EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc.
reported financial results for the three and nine months ended Sept. 30, 2023. Net product revenue from Avenova-branded eyecare products grew 7 percent year-over-year.
Monday, November 13, 2023 12:15 AM
DULUTH, Ga.—National Vision Holdings, Inc.
announced that it has entered into agreements with certain of the holders of its 2.50 percent Convertible Senior Notes due 2025 to repurchase $100 million aggregate principal amount of the 2025 Notes for an aggregate cash repurchase price of $99.25 million.
Friday, November 10, 2023 12:30 AM
DULUTH, Ga.—National Vision Holdings, Inc.
(NASDAQ: EYE) raised its adjusted earnings, net revenue and adjusted comparable store sales growth guidance for the full-year 2023, when it reported financial results for the third quarter and nine months ended Sept. 30, 2023. For fiscal 2023, the company now projects net revenue between $2.115 billion and $2.125 billion, with adjusted comparable store sales growth of about 2 percent. Previously, the company had anticipated fiscal 2023 net revenue between $2.075 billion and $2.135 billion, with adjusted comparable store sales growth of 0 percent to 3 percent.
Friday, November 10, 2023 12:27 AM
LONGARONE, Italy—Marcolin Group S.p.A
reported results for the nine months and third quarter of the year for the period ending Sept. 30, 2023, noting that in the first nine months, net sales rose by 3 percent compared to the same period of 2022, reaching €421.6 million. The first nine months closed with a net profit of €13.5 million (up €11.7 million compared to the comparable period a year ago. The company also noted adjusted EBITDA for the nine months was €64.6 million, an increase of 28 percent compared to €50.5 million in the first nine months of 2022.
Friday, November 10, 2023 12:24 AM
VANCOUVER, British Columbia—Kits Eyecare Ltd.
(TSX: KITS), a leading vertically integrated eyecare provider, reported its financial results for the third quarter ended Sept. 30, 2023. The company reported that revenue increased 32 percent to $31.2 million.
Thursday, November 9, 2023 12:27 AM
NEW YORK—Warby Parker Inc.
(NYSE: WRBY) reported that its net revenue rose in its third fiscal quarter ending Sept. 30, 2023 to $169.8 million, a 14.2 percent increase year over year. The company reported a GAAP net loss of $17.4 million for the period, improving by 6.4 million. Average revenue per customer increased 10 percent to $284, executives said, noting that its active customers increased 1.8 percent to 2.30 million in the period. Adjusted EBITDA was $11.0 million and adjusted EBITDA margin was 6.5 percent.
Monday, November 6, 2023 12:24 AM
PADUA, Italy—The board of directors of Safilo Group SpA
(SFLG.MI) has reviewed and approved the main economic and financial indicators for the third quarter and first nine months of 2023.
Monday, November 6, 2023 12:18 AM
LAKE FOREST, Calif.—STAAR Surgical Company
, a developer, manufacturer and marketer of implantable lenses for the eye, reported financial results for the third quarter ended Sept. 29, 2023. Net sales were $80.3 million for the third quarter of 2023.
Friday, November 3, 2023 12:27 AM
ALISO VIEJO, Calif.—Glaukos Corp.
(NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the third quarter ended Sept.30, 2023. Among the key highlights, the company reported net sales of $78.0 million, an increase of 10 percent year-over-year on a reported basis and 9 percent on a constant currency basis. Glaucoma net sales of $58.3 million in Q3 2023 increased 9 percent year-over-year while corneal health net sales of $19.7 million in Q3 2023 increased 12 percent year-over-year.
Thursday, November 2, 2023 12:24 AM
VAUGHAN, Ontario—Bausch + Lomb Corporation
, a leading global eye health company, announced its third-quarter 2023 financial results. Total reported revenues were $1.007 billion for the third quarter of 2023.
Wednesday, October 25, 2023 12:30 AM
PARIS—Within the Kering Group's (PARIS:KER) financial results for the third fiscal quarter of 2023, issued yesterday, the company reported global revenues for Kering Eyewear
for the period reached €330 million, an increase of 34 percent from the prior year's third quarter, the company said, citing the contribution of Maui Jim. Kering Eyewear sales in the Q3 were up 2 percent on a comparable basis. "Growth was mainly driven by sales of optical frames following very strong sales of sunglasses in the first half of the year," the company noted, adding in its presentation to the financial release that comparable growth was driven by Japan and APAC regions.
Friday, October 20, 2023 12:24 AM
(Reuters: ESLX.PA) announced yesterday that the group's consolidated revenue for the third quarter of 2023 totaled €6,294 million, representing a year-on-year increase of 5.2 percent at constant exchange rates compared to the third quarter of 2022 (-1.6 percent at current exchange rates), with sales strong in professional solutions (wholesale segment) and direct-to-consumer overall.